Ownership and insider activity for Avanos Medical, Inc. (AVNS): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management.
Price
| Price | $24.99 |
| Market Cap | $1.2B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-27 | Delgado Sigfrido | A-Award | 54,886 | |
| 2026-07-27 | Delgado Sigfrido | D-Return | 54,886 | $1.4M |
| 2026-07-27 | Delgado Sigfrido | D-Return | 37,520 | $514K |
| 2026-07-27 | Delgado Sigfrido | D-Return | 21,914 | $334K |
| 2026-07-27 | Galovan Scott Michael | A-Award | 96,121 | |
| 2026-07-27 | Galovan Scott Michael | D-Return | 96,121 | $2.4M |
| 2026-07-27 | Galovan Scott Michael | D-Return | 69,630 | $953K |
| 2026-07-27 | Galovan Scott Michael | D-Return | 21,038 | $321K |
| 2026-07-27 | Pacitti David | A-Award | 444,730 | |
| 2026-07-27 | Pacitti David | D-Return | 444,730 | $11.1M |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $113.7M | $219.7M | $384.5M | $205.3M | $111.5M | $118.5M | $127.7M | $87.7M | $107.7M | $89.8M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $188.5M | $203.0M | $150.5M | $163.8M | $167.9M | $131.2M | $167.9M | $142.8M | $132.8M | $103.8M |
| Inventory | $272.5M | $91.1M | $121.4M | $145.9M | $168.9M | $159.3M | $132.3M | $163.2M | $138.8M | $148.0M |
| Total Current Assets | $593.5M | $1.16B | $713.6M | $538.5M | $467.2M | $427.6M | $624.1M | $487.0M | $393.4M | $355.4M |
| Property, Plant & Equipment | $260.8M | $109.9M | $154.1M | $248.5M | $223.6M | $206.7M | $146.1M | $144.0M | $144.8M | $141.0M |
| Goodwill | $1.03B | $764.7M | $783.6M | $800.9M | $802.5M | $801.6M | $760.3M | $796.1M | $455.6M | $394.9M |
| Intangible Assets | $169.8M | $148.9M | $168.2M | $184.3M | $157.7M | $141.2M | $234.2M | $239.5M | $112.3M | $117.8M |
| Total Assets | $2.07B | $2.20B | $1.83B | $1.80B | $1.67B | $1.60B | $1.79B | $1.69B | $1.15B | $1.07B |
| Accounts Payable | $160.6M | $171.2M | $169.9M | $83.0M | $67.6M | $56.4M | $67.9M | $56.3M | $54.3M | $55.5M |
| Short-term Debt | 0 | $39.8M | 0 | 0 | 0 | $14.7M | $6.2M | $8.6M | $9.4M | $10.2M |
| Total Current Liabilities | $324.4M | $389.8M | $264.3M | $212.5M | $166.3M | $139.2M | $191.0M | $234.6M | $165.9M | $165.2M |
| Long-term Debt | $579.0M | $541.1M | $247.7M | $248.1M | $180.0M | $130.0M | $226.3M | $159.4M | $125.3M | $90.3M |
| Total Liabilities | $969.3M | $980.5M | $536.2M | $534.4M | $416.3M | $333.0M | $495.7M | $456.1M | $325.7M | $295.5M |
| Retained Earnings | -$379.2M | -$299.9M | -$242.4M | -$288.3M | -$315.5M | -$303.6M | -$253.1M | -$314.9M | -$707.0M | -$779.9M |
| Total Equity | $1.10B | $1.22B | $1.30B | $1.27B | $1.26B | $1.27B | $1.29B | $1.24B | $828.5M | $778.2M |
| Total Debt | $579.0M | $580.9M | $247.7M | $325.4M | $248.8M | $187.5M | $277.0M | $209.1M | $170.2M | $129.1M |
| Net Debt | $465.3M | $361.2M | -$136.8M | $120.1M | $137.3M | $69.0M | $149.3M | $121.4M | $62.5M | $39.3M |
| Working Capital | $269.1M | $770.9M | $449.3M | $326.0M | $300.9M | $288.4M | $433.1M | $252.4M | $227.5M | $190.2M |
Financial Health
| Debt / Equity | 0.18 |
| Current Ratio | 2.48 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 0.72 |
Profitability
| Return on Equity | -8.91% |
| Return on Invested Capital | -6.03% |
| Return on Assets | -6.61% |
| Gross Margin | 48.55% |
| Operating Margin | -7.92% |
| Net Margin | -9.69% |
Related companies: AORT · AXGN · CVSA · ITGR · LIVN · VREX
Explore sector: Healthcare · Medical - Devices
More sections of AVNS: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks